Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Novosteo logo — Innovative solutions for bone recovery and health, accelerat...

Novosteo

Innovative solutions for bone recovery and health, accelerating healing with precision-targeted treatments.

Founded 2017 Series A Total: $7.95M Biotechnology, Health Care +1

General Information

Company Name Novosteo
Founded Year 2017
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Series A
Social

Get notified when Novosteo moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Novosteo

Novosteo is a biotechnology startup founded in 2017 with a mission to revolutionize bone recovery and health. The company's innovative solutions focus on accelerating healing with precision-targeted treatments. Utilizing a unique chemistry method for bone targeting and discovering new biologics, Novosteo aims to address issues related to patients' morbidity, mortality, and loss of mobility and productivity due to bone fractures, bone metastasis, and infections. The scientific co-founders, Stewart Low and Philip Low from Purdue University, have spearheaded the development of medications that speed up bone regeneration by delivering anabolic agents specifically to fracture surfaces. In January 2021, Novosteo secured a significant $5.50M Series A investment from prominent investors including Elevate Ventures, Kairos Ventures, BioCrossroads, and the Purdue Research Foundation. This funding injection not only validates the potential of Novosteo's groundbreaking approach but also provides the necessary resources to drive further research and development initiatives. As Novosteo continues to make strides in the biotechnology, healthcare, and pharmaceutical industries, its innovative solutions hold promise for transforming the treatment of bone injuries and diseases, ultimately improving patient outcomes and quality of life.

Taxonomy: bone recovery, precision-targeted treatments, medications, bone injuries, bone diseases, fracture treatment, biologics, bone regeneration, anabolic agents, precision medicine, biomedical technology, scientific research, startup, medical advancements

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 4
Investor Investor Investor
•••• •••• 		13 Jan 2021
Seed Round •••••• 1
Investor
09 Aug 2019
Pre Seed Round •••••• 1 •••• •••• 20 Dec 2018
Grant •••••• 1 •••• •••• 27 Sep 2018

Novosteo Alternatives & Competitors

Novosteo vs
Flow-FX
Flow-FX United States

Treat the BONE: Precision Delivery for Diseased Bone

5 employees
Medical Devices
Novosteo vs
RevBio, Inc.
RevBio, Inc. United States

Transforming Bone Repair

Grant
32 employees
Biotechnology, Health Care
Novosteo vs
Inossia AB
Inossia AB Sweden

Active aging, better treatments and reduced healthcare costs for patients with vertebral fractures.

Series Unknown
11 employees
Also compare with: Novosteo vs GreenBone Ortho GreenBone Ortho

FAQ About Novosteo

Innovative solutions for bone recovery and health, accelerating healing with precision-targeted treatments.
Novosteo was founded in 2017.
Novosteo operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
Novosteo has completed 4 funding rounds, raising a total of $7.95M. The latest funding stage is Series A.
Top alternatives and competitors to Novosteo include Flow-FX, RevBio, Inc., Inossia AB, 3D Orthobiologic Solutions (3DOS), Novara Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Novosteo and Flow-FX are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Novosteo and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy